Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Sep 4, 2015 (11 years ago)

Fenoglide (fenofibrate)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications: Failed 24 month dissolution testing.

Cause type: Dissolution failure

The tablet or capsule did not dissolve within specification. Dissolution controls how much drug the body absorbs; a failure can change the effective dose. All dissolution failure recalls.

What was recalled

Fenoglide (fenofibrate) tablets, 120 mg Tablets, 90 Ct Bottle, Rx Only. Distributed by: Santarus, Inc. San Diego, CA 92130. NDC: 68012-495-90.

Affected NDC 68012-0495-90

Compare with the code on your package — it is the most precise check available.

Drug: Fenofibrate Category: Cholesterol Medication

Recalling firm
Valeant Pharmaceuticals North America LLC
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0163-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Fenofibrate recalls

See all
Class II · Moderate risk

Fenofibrate Capsules

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. D-0407-2021
Class III · Low risk

Fenofibrate Tablets

Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.

Terminated Particulate / foreign matter Hetero Labs, Ltd. - Unit III NDC 31722-596-90 D-1211-2018
Class III · Low risk

Fenofibrate Capsules

Labeling: Incorrect or Missing Lot and/or Exp Date

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-835-32 D-0823-2016

Other recalls by Valeant Pharmaceuticals North America LLC

All 2015 recalls
Class III · Low risk

Diltiazem HCl CD capsules

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Terminated Dissolution failure Valeant Pharmaceuticals North America LLC NDC 68682-521-01 D-0491-2019
Class III · Low risk

Cardizem CD

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Terminated Dissolution failure Valeant Pharmaceuticals North America LLC NDC 0187-0798-30 D-0490-2019
Class III · Low risk

Cardizem CD

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Terminated Dissolution failure Valeant Pharmaceuticals North America LLC NDC 0187-0797-30 D-0489-2019
Class III · Low risk

Cardizem CD

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Terminated Dissolution failure Valeant Pharmaceuticals North America LLC NDC 0187-0796-30 D-0488-2019